How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegeneration through toll-like receptor TLR signaling and short-chain fatty acids SCFAs

RESOLVED

How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegeneration through toll-like receptor TLR signaling and short-chain fatty acids SCFAs

Priority: 0.90 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegeneration through toll-like receptor TLR signaling and short-chain fatty acids SCFAs is a 0.9 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.343. Status: resolved.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegeneration through toll-like receptor TLR signaling and short-chain fatty acids SCFAs — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.346
Top Score
0.343
Avg Score
4
Debates
0.76
Avg Quality
100%
Resolution
0
Mechanistic Families
Gap Resolution Progress100%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)
plasma LPS-binding protein separates causal from compensatory states i
Target: plasma LPS-binding protein Pathway: SCFA depletion
0.346
score
TLR4 priming is the actionable driver in: How does gut microbiome dysb
Target: TLR4 priming Pathway: TLR4 priming
0.343
score
microglial inflammasome tone defines the therapeutic window for: How d
Target: microglial inflammasome tone Pathway: microglial inflammasome tone
0.341
score
🌊 Knowledge Graph Connections

activates (24)

TLRAlsTLRInflammationINFLAMMATIONTLRTLRToll-Like ReceptorSCFAsFFAR2
▸ Show 19 more

associated with (2)

TLRToll-Like ReceptorTLRInflammation

encodes (1)

TLRTLR

inhibits (5)

TLRToll-Like ReceptorNF-ΚBTLRTLRNf-ΚbTLRGENESPI3KTLR

interacts with (1)

NFKBTLR

participates in (1)

TLRJAK-STAT signaling

regulates (10)

TLRInflammationINFLAMMATIONTLRTLRCancerTLRAlsTLRneuroinflammation
▸ Show 5 more

therapeutic target (6)

TLRIschemiaTLRTumorTLRCancerTLRAlsTLRInflammation
▸ Show 1 more
🕑 Activity Feed
update on knowledge_gap by None 2026-04-28T12:13
update on knowledge_gap by None 2026-04-28T12:10
update on knowledge_gap by None 2026-04-28T12:10
update on knowledge_gap by None 2026-04-28T12:10
update on knowledge_gap by None 2026-04-28T12:10
🎭 How does gut microbiome dysbiosis contribute to neuroinflamm q=0.76 2026-04-26T16:27
🎭 Formal debate: TLR4 priming is the actionable driver in: How q=0.75 2026-04-26T15:49
🎭 Formal debate: plasma LPS-binding protein separates causal f q=0.75 2026-04-26T15:49
🎭 How does gut microbiome dysbiosis contribute to neuroinflamm q=0.78 2026-04-26T14:17
💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps